Clovis Oncology to Present at the Bank of America Merrill Lynch 2013 Health
Care Conference in Las Vegas
Bank of America Merrill Lynch 2013 Healthcare Conference
BOULDER, Colo. -- May 08, 2013
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Erle T. Mast, the
Company’s Chief Financial Officer and Executive Vice President, will present
at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday,
May 15, 2013, at 10:40 AM PDT. The conference will be held at the Encore at
the Wynn in Las Vegas.
A live webcast of the presentation can be accessed through the investor
relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be available on
the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado, and has additional offices in San
Francisco, California and Cambridge, UK.
Anna Sussman, 303-625-5022
Breanna Burkart, 303-625-5023
Press spacebar to pause and continue. Press esc to stop.